Updated September 2026503B facility named as sourceLiberty review
The preparation is sourced from a 503B outsourcing facility, which is a different regulatory category from a retail compounding pharmacy.
The verdict
Liberty prices compounded semaglutide at a flat $199 a month and compounded tirzepatide at a flat $299. Both are stated to come from a 503B outsourcing facility, after a clinician review. The facility type is the fact worth reading here.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Liberty sells compounded semaglutide and compounded tirzepatide as weekly injections. The two figures read $199 and $299 a month on August 15, 2026. A three-month supply brings the semaglutide to about $171 a month. Both rates are described as flat at every dose.
Who writes the prescription, and what do they see?
The prescription follows a clinician review rather than an automatic approval at checkout. That sequence is stated on the product pages for both molecules. What the review consists of, and whether it is live or asynchronous, is not published. The rate does not change with the outcome of the review.
Treatment is arranged remotely and the injection is weekly. The tirzepatide is described as a dual GIP and GLP-1 agonist, which is what the molecule is. Liberty prices the two molecules $100 apart. Liberty describes no coaching or check-in program alongside the medication.
What happens when the dose goes up?
Both rates are stated as flat at every dose. A reader who reaches a maintenance dose in month four pays the same as in month one. Whether a dose change requires a further clinician review is not stated beside the price. The three-month supply is a prepay rather than a different rate.
What the price includes
$199 and $299 are month-to-month figures, and the three-month route drops the semaglutide to roughly $171. The $100 step between molecules is the widest part of this seller's pricing. No state list is published, so a reader confirms coverage at intake. Nothing beside either figure was recorded as a separate charge on August 15, 2026.
What it claims, and what it cites
A 503B outsourcing facility registers with the FDA and makes products under current good manufacturing practice, which a 503A pharmacy does not. That is a real distinction, and it is not the same as approval: a compounded semaglutide from a 503B is still not an FDA-approved drug. The outcome trials used the approved products at label doses. Whether a 503B preparation matches them in content or purity is not measured here.
Where it holds up, and where it does not
- Strength: Pharmacy type named, not implied
- Strength: Clinician review stated before prescribing
- Strength: Rate flat at every dose
- Limitation: No state list published
- Limitation: Tirzepatide costs $100 more
- Limitation: Facility name itself not published
What the evidence says about this kind of treatment
The assessment above is about Liberty. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing.
- Wrong for
- A reader shopping the compounded market on price alone, since flat pricing and a named facility type are what the higher figure buys.
How Liberty compares
| Seller | Who it suits | Go |
|---|---|---|
| Harper Meds | A reader who wants a clinician, a prescription and the medication under one charge, with no term to commit to before reaching the published rate. | See Harper Meds → |
| Apex MD | A reader who wants a month-to-month plan with no prepay commitment, and who is told what is in the vial before ordering. | See Apex MD → |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. | See EverSlim → |
More GLP-1 telehealth sellers reviews: CoreAge RxStrut HealthSynergy RxAlan MedsAlloyAVARA Rx
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is a 503B outsourcing facility?
- It is a compounder registered with the FDA that makes products in batches under current good manufacturing practice. A 503A pharmacy compounds for individual prescriptions and is not held to that standard.
- Does that make the medication FDA-approved?
- No. A compounded preparation from a 503B facility is still not an FDA-approved drug and is not reviewed for safety or efficacy before it is dispensed.
- Does the price rise with the dose?
- Liberty states a flat rate at every dose on both molecules. A three-month supply lowers the semaglutide figure to about $171 a month, paid up front.
- Is Liberty expensive compared with other GLP-1 telehealth sellers?
- Liberty publishes a starting figure of $199/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Liberty above the median. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.